An ASNC Information Statement: Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis
Resource Type
Information Statements, Practice Points
Year Published
2022
Related Resources
Cases
PET Case: Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA)
Case summary: This case illustrates the role of multimodality imaging in diagnosing…
Cases
PET Case: A Case of Pacemaker Lead Infection in Patient with S. Lugdunensis Bacteremia
Case summary: 64-year-old female with history of CRT-D implantation admitted with acute…
ASNC Comments to CMS on 2026 Medicare Physician Fee Schedule Proposed Rule
ASNC_Comments-to-CMS-on_CY2026-MPFS-Proposed-Rule_1832_09-12-2025_FINAL
